Clinical Trial Update: Efficacy of BNG-1 to Treat Acute Ischemic Stroke [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating BNG-1 for acute ischemic stroke has completed, reporting efficacy findings.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• BNG-1

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Ischemic Stroke | Phase 3 | Status: COMPLETED